01.03.2006 21:22:00

David G. Bills to Lead DuPont Global Biotechnology, Cynthia C. Green to Lead DuPont Fluoroproducts

WILMINGTON, Del., March 1 /PRNewswire-FirstCall/ -- DuPont today announced that effective March 1, David G. Bills, 44, is named vice president and general manager - DuPont Global Biotechnology. He will be responsible for accelerating the introduction of DuPont biotechnology into key global markets.

"I am pleased to have David's creativity, strategic insight and passion for growth focused on expanding our global presence in biotechnology - a critical growth area for DuPont," said DuPont Chairman & CEO Charles O. Holliday, Jr.

Bills joined the company in 2001 from McKinsey & Company, where he was a partner and co-led the Worldwide Growth Strategy Practice. His assignments in DuPont have included vice president - DuPont Corporate Plans, vice president and general manager - DuPont Displays and vice president and general manager - DuPont Fluoroproducts.

Bills will be succeeded by Cynthia C. Green. Green, 49, is currently global business director - DuPont Fluoropolymer Solutions. Green has held a number of leadership positions in DuPont Chemical Solutions Enterprise, DuPont Titanium Technologies and DuPont Fluoroproducts. She joined DuPont in 1979.

DuPont is a science company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture, nutrition, electronics, communications, safety and protection, home and construction, transportation and apparel.

Bios and photos are available at: http://www2.dupont.com/Our_Company/en_US/executives/alpha.html.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu DuPont (E. I. DuPont de Nemours and Co.)mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu DuPont (E. I. DuPont de Nemours and Co.)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

Dow Jones 44 424,25 -0,32%
S&P 500 6 101,24 -0,29%
S&P 100 2 980,92 -0,30%
NYSE US 100 17 129,98 1,09%